Allay doses first subject in trial of ATX101 for post-surgical pain relief

cafead

Administrator
Staff member
  • cafead   Feb 19, 2025 at 11:02: AM
via Allay Therapeutics has dosed the first subject in the randomised Phase IIb registration trial of its investigational analgesic, ATX101, designed to provide extended pain relief following total knee replacement surgery.

article source